Participants
anovulation, PCOS, infertility, hyperandrogenemia, oligo-ovulation
ANOVULATION
The first participant became involved on 3 April 2023, and the final participant accomplished the study on 31 July 2023. Outpatients with PCOS and infertility who desired to conceive were evaluated using inclusion and exclusion criteria to identify those who were suitable and had no other definite causes of infertility. Inclusion criteria involved: (i) PCOS patients who met the Rotterdam criteria in 2003 (diagnosis can be created if two of three are present): oligo-ovulation or anovulation, clinical or biochemical hyperandrogenemia, polycystic ovary/ies changes under ultrasound (Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group, 2004) (